Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.035
-0.025 (-2.36%)
At close: May 16, 2025, 4:00 PM
1.030
-0.005 (-0.49%)
After-hours: May 16, 2025, 7:59 PM EDT
PACB Market Cap
PACB has a market cap or net worth of $310.59 million as of May 16, 2025. Its market cap has decreased by -29.75% in one year.
Market Cap
310.59M
Enterprise Value
669.59M
1-Year Change
-29.75%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $310.59M, a decrease of -62.30%. That is a compound annual growth rate of -6.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 15, 2025 | 318.10M | -36.53% |
Dec 31, 2024 | 501.20M | -80.90% |
Dec 29, 2023 | 2.62B | 41.85% |
Dec 30, 2022 | 1.85B | -59.02% |
Dec 31, 2021 | 4.51B | -3.45% |
Dec 31, 2020 | 4.67B | 494.29% |
Dec 31, 2019 | 786.60M | -28.61% |
Dec 31, 2018 | 1.10B | 259.04% |
Dec 29, 2017 | 306.90M | -12.84% |
Dec 30, 2016 | 352.10M | -65.19% |
Dec 31, 2015 | 1.01B | 80.82% |
Dec 31, 2014 | 559.40M | 61.68% |
Dec 31, 2013 | 346.00M | 262.30% |
Dec 31, 2012 | 95.50M | -37.79% |
Dec 30, 2011 | 153.50M | -81.73% |
Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 655.79B |
Johnson & Johnson | 359.32B |
AbbVie | 314.37B |
Novo Nordisk | 288.64B |
UnitedHealth Group | 238.03B |
Abbott Laboratories | 229.94B |
Novartis AG | 208.47B |
AstraZeneca | 206.71B |